SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME

Date
2015
Author
Utku, Irem
Harmankaya, Ozlem
Demir, Esra
Kocoglu, Hakan
Ucak, Sema
Serin, Sibel Ocak
OKUTURLAR, Yıldız
GEDİKBAŞI, Asuman
Metadata
Show full item record
Abstract
Introduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).
URI
http://hdl.handle.net/20.500.12627/138251
Collections